AT-13148

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAT-13148
Drug Alias NameAT-13148
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsRho-associated protein kinase 2 inhibitorsProtein kinase C inhibitors +[6] 
Targets70-kDa ribosomal protein S6 kinasesSerine/threonine-protein kinase AKT1Rho-associated protein kinase 1 +[6] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A